ABSTRACT
Introduction Health risk assessment (HRA) strategies are cornerstone for health systems transformation toward value-based patient-centred care. However, steps for HRA adoption are undefined. This report analyses the process of transference of the Adjusted Morbidity Groups (AMG) algorithm from the Catalan Good Practice to the Marche region (IT) and to Viljandi Hospital (EE), within the JADECARE initiative (2020–2023).
Description The implementation research approach involved a twelve-month pre-implementation period to assess feasibility and define the local action plans, followed by a sixteen-month implementation phase. During the two periods, a well-defined combination of experience-based co-design and quality improvement methodologies were applied.
Discussion The evolution of the Catalan HRA strategy (2010–2023) illustrates its potential for health systems transformation, as well as its transferability. The main barriers and facilitators for HRA adoption were identified. The report proposes a set of key steps to facilitate site customized deployment of HRA contributing to define a roadmap to foster large-scale adoption across Europe.
Conclusions Successful adoption of the AMG algorithm was achieved in the two sites confirming transferability. Marche identified the key requirements for a population-based HRA strategy, whereas Viljandi Hospital proved its potential for clinical use paving the way toward value-based healthcare strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by JADECARE project-HP-JA-2019 - Grant Agreement n. 951442 a European Union Health Program 2014-2020.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research exclusively employed fully anonymized retrospective health records sourced from administrative databases. Consequently, in compliance with prevailing legislation in the regions where the analyses were conducted, neither informed consent nor ethical committee approval was required. All the analytical procedures were undertaken under the auspices of the JADECARE project.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Due to the nature of the research and to ethical aspects, supporting data is not available.
ACRONYMS
- ACP
- Advanced Chronic Patients
- AMG
- Adjusted Morbidity Groups
- CCP
- Complex Chronic Patients
- COPD
- Chronic Obstructive Pulmonary Disease
- CRG
- Clinical Risk Groups
- GDPR
- General Data Protection Regulation
- HAD
- Healthcare Administrative Database
- HRA
- Health Risk Assessment
- KPI
- Key Performance Indicator
- LAP
- Local Action Plan
- MSIQ
- Modules for Monitoring Quality Indicators (“Moduls pel Seguiment d’Indicadors de Qualitat”)
- NA
- Next Adopter
- NCD
- Non-Communicable Disease
- oGP
- Original Good Practice
- PDSA
- Plan-Do-Study-Act
- PREM
- Patient Reported Experience Measure
- PROM
- Patient Reported Outcome Measure